@entity209 is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute XXXX .

@entity1 @entity296 @entity731 @entity6949 @entity1188 @entity209 @entity583 @entity165
BACKGROUND: Infarct size is an important surrogate end point for early and late mortality after @entity583 . Despite the high prevalence of @entity209 in @entity1 with @entity731 , adequate data are still lacking regarding the extent of @entity296 after @entity583 in these @entity1 . OBJECTIVES: In the present study we aimed to compare @entity583 size in @entity1 with @entity209 to those without @entity209 using peak CK-MB and @entity6949 ( @entity6949 ) at 72 hours after the onset of symptoms. @entity1 AND METHODS: One-hundred @entity1 with @entity209 (group I) and 100 control subjects without @entity209 (group II) who experienced @entity583 were included in the study. Diagnosis of @entity209 was based on the National @entity165 Education Program Adult Treatment Panel III (NCEP ATP III) guidelines published in 2001. @entity583 size was compared between the two groups of @entity1 using peak CK-MB and @entity6949 level in 72 hours after the onset of symptoms. RESULTS: Peak CK-MB and @entity6949 in 72 hours were found to be significantly higher in @entity1 with @entity209 compared with control subjects (both P < 0.001). @entity1 with @entity209 also had markedly higher wall motion abnormality at 72 hours after the onset of symptoms as assessed by echocardiographically-derived Wall Motion Score Index (WMSI) (P < 0.001). Moreover, statistically significant relationships were found between WMSI and peak CK-MB and also @entity6949 at 72 hours (Spearman's rho = 0.56, P < 0.001 and Spearman's rho = 0.5, P < 0.001; respectively). However, association between WMSI and left ventricular ejection fraction was insignificant (Spearman's rho = -0.05, P = 0.46). CONCLUSIONS: We showed that @entity1 with @entity209 have larger @entity1188 size compared to control subjects.
